FOUNDATION COLLABORATION The Blue Angels Foundation
The Research and Recognition Project is proud to be collaborating with The Blue Angels Foundation to conduct the San Diego Replication Study Pilot. Click on the following link to learn about R&RP on the Blue Angels website.
Retired Rear Admiral H. Denny Wisely, former Captain of the aircraft carrier, U.S.S. JOHN F. KENNEDY, “Boss” Wisely skeptically heard about the RTM Protocol from a friend. He had the Project treat two PTSD affected veterans in San Diego and after observing the results first hand, the rest, as they say, is history.
Blue Angel Foundation Board Members
Mike Campbell, President
Russ Holden, Executive Director
Privately funded by the Blue Angels Foundation, the first thirty veteran wait list controlled replication of the RTM protocol uses rigorous scientific methods including, independent “blind” psychometricians and statistical analysis. 28 of the 30 (93%) Experimental and Control Group participants were free of PTSD at the two week follow-up. The Blue Angels have also taken primary funding responsibility for the second thirty veteran replication study which is treating female veterans in San Diego.
The Research and Recognition Project is proud to be collaborating with several Universities. Their research and support brings an important element of impartiality to our research, further helping to prove the efficacy of the protocols.
As part of the ongoing research program at the Middletown, New York site, we have partnered with Stephen J. Glatt, PhD. Dr. Glatt is Associate Professor of Psychiatry and Behavioral Sciences, and of Neuroscience and Physiology, as well as Associate Director of Medical Genetics Research at SUNY Upstate Medical University. He is developing a gene-based biomarker for the presence and alleviation of PTS. He and his staff are participants in the ongoing research at Middletown by providing not only the blood-biomarker analyses, but also performing the statistical analyses for the project at no cost.
Bradley University in Ohio has signed a letter of intent to perform a pilot study similar to the one at Middletown with the use of functional Magnetic Resonance Imaging (fMRI) to confirm the presence and resolution of PTS. That enterprise has engaged Lori A. Russell-Chapin, PhD, Professor and Associate Dean of the College of Education and Health Sciences as Primary Investigator; Celia Johnson, Ed.D., Professor of Education as Research Specialist; and Nancy E. Sherman, PhD, Professor of Leadership in Education, and clinical coordinator for the Human Development Counseling program as Clinical Coordinator. The Team at Bradley has already obtained preliminary funding, and RTM training for their clinicians has been scheduled. As part of the plan of research we will be collaborating with them in the creation of a graduate clinical program, with an emphasis on NLP and its techniques.
Universities in North Carolina
Letters of intent and initial funding has been obtained for researchers from the University of North Carolina in a collaborative pilot of the RTM protocol using EEG imaging and physiological markers to test the protocol. Part of the study will include the development of training materials for other studies at other Universities. Connie Schrader, MA, Lecturer in human wellness will serve as Clinical Director.
Dr. Karen Selz, Director and Senior Scientist, Cielo Institute, Inc. (Non-salaried), Research Assistant Professor of Psychiatry, Emory University School of Medicine; Adjunct Professor of Mathematical Sciences, FAU, Boca Raton, Fl. will serve as Principal Investigator.
University of New Mexico
We have entered into an agreement with the University of New Mexico for a third pilot study. This one will use Magneto Encephalographic Analysis (MEG) to test for PTS and its alleviation. Jeffrey D. Lewine, PhD, is Research Associate Professor at the University of New Mexico, and Professor of Translational Neuroscience, and Director of Business Development at the Mind Research Network. He is PI of the anticipated collaboration.